Literature DB >> 18928382

Robot-assisted laparoscopic radical prostatectomy in the renal allograft transplant recipient.

Jay K Jhaveri1, Gerald Y M Tan, Douglas S Scherr, Ashutosh K Tewari.   

Abstract

BACKGROUND AND
PURPOSE: Since the advent of immunosuppressive therapy, patients have been able to lead longer lives as transplant recipients. We report the first case of robot-assisted laparoscopic prostatectomy in the renal allograft recipient. PATIENTS AND METHODS: A 54-year-old man presented with Gleason 3+3 localized prostate cancer with a prostatespecific antigen level of 8.5 ng/mL. He had a history of end-stage renal failure secondary to fulminant acute pyelonephritis necessitating bilateral nephrectomy. Renal allograft transplant in the right iliac fossa was performed in 1981, with adequate renal function while continuing his immunosuppressant regime. The patient also had previous left inguinal herniorrhaphy. Modifications to our surgical approach include placement of a bariatric port superiolaterally to the standard port site; siting the left port inferiolaterally to provide adequate access for pelvic lymph node dissection; and developing the retropubic space largely from the contralateral side to avoid allograft injury. Extensive adhesiolysis was also needed. After negative urethral margin reported on frozen section, vesicourethral anastomosis was fashioned using our Cornell bladder neck anatomic reconstruction technique.
RESULTS: The patient needed a postoperative transfusion of 1 unit of blood and was discharged on postoperative day 2 after recommencement of immunosuppression. The final pathology report revealed pT(2c) Gleason 7 (3+4) disease and negative surgical margins. Continence was recovered within the first week of catheter removal, and erections sufficient for penetration occurred before 6-week follow-up in the clinic.
CONCLUSION: Robot-assisted radical prostatectomy is feasible in the carefully selected renal allograft recipient with favorable oncologic, continence, and potency outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18928382     DOI: 10.1089/end.2008.0280

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

1.  Technical feasibility of robot-assisted laparoscopic radical prostatectomy in renal transplant recipients: Results of a series of 12 consecutive cases.

Authors:  Quentin-Côme Le Clerc; Emilie Lecornet; Gregoire Leon; Jerome Rigaud; Pascal Glemain; Julien Branchereau; Georgess Karam
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Robot-Assisted Radical Prostatectomy in a Second Kidney Transplant Recipient.

Authors:  Keita Minami; Hiroshi Harada; Hajime Sasaki; Haruka Higuchi; Hiroshi Tanaka
Journal:  J Endourol Case Rep       Date:  2020-12-29

3.  Radical retropubic and perineal prostatectomy for clinically localised prostate cancer in renal transplant recipients.

Authors:  Axel Heidenreich; David Pfister; Andrea Thissen; Charlotte Piper; Daniel Porres
Journal:  Arab J Urol       Date:  2014-02-20

Review 4.  Prostate cancer in renal transplant recipients.

Authors:  Benjamin A Sherer; Krishnan Warrior; Karl Godlewski; Martin Hertl; Oyedolamu Olaitan; Ajay Nehra; Leslie Allan Deane
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541

5.  Oncological and Functional Outcomes of Robot-Assisted Radical Prostatectomy in Kidney Transplant Recipients.

Authors:  Mohammed Shahait; Fawaz Al Majali; Ryan W Dobbs; Alex Sandberg; Adnan El-Achkar; Ayah El-Fahmawi; Philip Mucksavage; David I Lee
Journal:  JSLS       Date:  2021 Jul-Sep       Impact factor: 2.172

6.  Modifications to facilitate extraperitoneal robot-assisted radical prostatectomy post kidney transplant.

Authors:  Ahmed Ghazi; Erdal Erturk; Jean V Joseph
Journal:  JSLS       Date:  2012 Apr-Jun       Impact factor: 2.172

7.  Transperitoneal Robot-Assisted Radical Prostatectomy Should Be Considered in Prostate Cancer Patients with Pelvic Kidneys.

Authors:  Sophie Plagakis; Darren Foreman; Peter Sutherland; Andrew Fuller
Journal:  J Endourol Case Rep       Date:  2016-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.